e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of different asthma treatments on risk of cold-related exacerbations
Reddel H.K., Jenkins C., Quirce S., Sears M.R., Bateman E.D., O’Byrne P.M., Humbert M., Buhl R., Harrison T., Brusselle G.G., Thorén A., Sjöbring U., Peterson S., Östlund O., Eriksson G.S.
Source:
Eur Respir J 2011; 38: 584-593
Journal Issue:
September
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Reddel H.K., Jenkins C., Quirce S., Sears M.R., Bateman E.D., O’Byrne P.M., Humbert M., Buhl R., Harrison T., Brusselle G.G., Thorén A., Sjöbring U., Peterson S., Östlund O., Eriksson G.S.. Effect of different asthma treatments on risk of cold-related exacerbations. Eur Respir J 2011; 38: 584-593
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Reducing the risk of COPD exacerbations as results of personalized therapy of co-morbidity with upper respiratory tract diseases
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Christmas as a risk factor for exacerbations of COPD, adult asthma and respiratory infections
Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Year: 2007
Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005
Perennial allergy is a modifiable risk factor for exacerbations and respiratory infections in asthma patients
Source: Virtual Congress 2020 – Determinants of chronic respiratory diseases
Year: 2020
Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD
Source: Eur Respir J 2009; 33: 282-288
Year: 2009
Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Management of lower respiratory tract infections by French general practitioners: the AIR II study
Source: Eur Respir J 2002; 19: 314-319
Year: 2002
Risk factors of frequent exacerbations in difficult-to-treat asthma
Source: Eur Respir J 2005; 26: 812-818
Year: 2005
Prevention of exacerbations of COPD with pharmacotherapy
Source: Eur Respir Rev 2009; 19: 119-126
Year: 2010
Association of asthma exacerbations and upper respiratory tract infections (URTIs)
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009
The risk of respiratory tract infections and antibiotic use in a general population and among people with asthma
Source: ERJ Open Res, 7 (4) 00429-2021; 10.1183/23120541.00429-2021
Year: 2021
The efficacy of multiple use of interferon-gamma inducer in treatment of recurrent acute respiratory viral infections in children with bronchial asthma
Source: Annual Congress 2013 –Preschool wheeze
Year: 2013
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Epidemiology of respiratory infection in children
Source: Annual Congress 2005 - PG5 - Paediatrics: respiratory infections in children
Year: 2005
Viral etiologies in childhood wheezing illness, asthma and respiratory infections
Source: International Congress 2019 – Aetiology and management of childhood respiratory infections, primary ciliary dyskinesia and asthma
Year: 2019
Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Mechanisms of exacerbation of respiratory symptoms in patients with COPD
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Telithromycin is effective in the treatment of patients with acute exacerbations of chronic bronchitis and risk factors for morbidity
Source: Eur Respir J 2002; 20: Suppl. 38, 545s
Year: 2002
The role of viral infections in asthma and asthma exacerbations
Source: Annual Congress 2010 - ERS/[italic]Lancet[/italic] Asthma
Year: 2010
Diagnosing viral and bacterial respiratory infections in acute COPD exacerbations by electronic nose
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept